Výsledky vyhledávání - Moretto, Roberto
- Zobrazuji výsledky 1 - 15 z 15
-
1
-
2
-
3
Bevacizumab maintenance in metastatic colorectal cancer: How long? Autor De Stefano, Alfonso, Moretto, Roberto, Cella, Chiara Alessandra, Romano, Francesco Jacopo, Raimondo, Lucia, Fiore, Giovanni, Di Pietro, Francesca, Pepe, Stefano, De Placido, Sabino, Carlomagno, Chiara
Vydáno 2014Text -
4
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? Autor Dell’Aquila, Emanuela, Zeppola, Tea, Stellato, Marco, Pantano, Francesco, Scartozzi, Mario, Madaudo, Cristina, Pietrantonio, Filippo, Cremolini, Chiara, Aprile, Giuseppe, Vincenzi, Bruno, Moretto, Roberto, Puzzoni, Marco, Garattini, Silvio Ken, Lobefaro, Riccardo, Tonini, Giuseppe, Santini, Daniele
Vydáno 2020Text -
5
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study Autor Cella, Chiara Alessandra, Di Minno, Giovanni, Carlomagno, Chiara, Arcopinto, Michele, Cerbone, Anna Maria, Matano, Elide, Tufano, Antonella, Lordick, Florian, De Simone, Biagio, Muehlberg, Katja Sibylle, Bruzzese, Dario, Attademo, Laura, Arturo, Claudia, Sodano, Marta, Moretto, Roberto, La Fata, Ersilia, De Placido, Sabino
Vydáno 2017Text -
6
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study Autor Cremolini, Chiara, Pietrantonio, Filippo, Tomasello, Gianluca, Dadduzio, Vincenzo, Moretto, Roberto, Morano, Federica, Schirripa, Marta, Antoniotti, Carlotta, Fucà, Giovanni, Bergamo, Francesca, Rossini, Daniele, Nichetti, Federico, Ziampiri, Stamatia, Ghidini, Michele, Marmorino, Federica, Prisciandaro, Michele, Falcone, Alfredo, De Braud, Filippo, Loupakis, Fotios, Lonardi, Sara
Vydáno 2017Text -
7
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable Autor Ongaro, Elena, Cremolini, Chiara, Rossini, Daniele, Corti, Francesca, Pagani, Filippo, Morelli, Luca, Urbani, Lucio, Masi, Gianluca, Sposito, Carlo, Filippi, Beatrice, Borelli, Beatrice, Zucchelli, Gemma, Moretto, Roberto, Boccaccino, Alessandra, Solaini, Leonardo, de Braud, Filippo, Mazzaferro, Vincenzo, Falcone, Alfredo, Cucchetti, Alessandro, Pietrantonio, Filippo
Vydáno 2019Text -
8
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies Autor Moretto, Roberto, Rossini, Daniele, Conca, Veronica, Lonardi, Sara, Rasola, Cosimo, Antoniotti, Carlotta, Santini, Daniele, Marmorino, Federica, Tomasello, Gianluca, Borelli, Beatrice, Caponnetto, Salvatore, Zucchelli, Gemma, Zaniboni, Alberto, Ambrosini, Margherita, Buonadonna, Angela, Fanchini, Laura, Cupini, Samanta, Masi, Gianluca, Falcone, Alfredo, Cremolini, Chiara
Vydáno 2021Text -
9
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Autor Moretto, Roberto, Cremolini, Chiara, Rossini, Daniele, Pietrantonio, Filippo, Battaglin, Francesca, Mennitto, Alessia, Bergamo, Francesca, Loupakis, Fotios, Marmorino, Federica, Berenato, Rosa, Marsico, Valentina Angela, Caporale, Marta, Antoniotti, Carlotta, Masi, Gianluca, Salvatore, Lisa, Borelli, Beatrice, Fontanini, Gabriella, Lonardi, Sara, De Braud, Filippo, Falcone, Alfredo
Vydáno 2016Text -
10
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO Autor Rossini, Daniele, Lonardi, Sara, Antoniotti, Carlotta, Santini, Daniele, Tomasello, Gianluca, Ermacora, Paola, Germani, Marco Maria, Bergamo, Francesca, Ricci, Vincenzo, Caponnetto, Salvatore, Moretto, Roberto, Zaniboni, Alberto, Pietrantonio, Filippo, Buonadonna, Angela, Ritorto, Giuliana, Masi, Gianluca, Latiano, Tiziana Pia, Rapisardi, Stefania, Falcone, Alfredo, Cremolini, Chiara
Vydáno 2020Text -
11
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorec... Autor Antoniotti, Carlotta, Borelli, Beatrice, Rossini, Daniele, Pietrantonio, Filippo, Morano, Federica, Salvatore, Lisa, Lonardi, Sara, Marmorino, Federica, Tamberi, Stefano, Corallo, Salvatore, Tortora, Giampaolo, Bergamo, Francesca, Brunella, Di Stefano, Boccaccino, Alessandra, Grassi, Elisa, Racca, Patrizia, Tamburini, Emiliano, Aprile, Giuseppe, Moretto, Roberto, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Vydáno 2020Text -
12
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer Autor Cremolini, Chiara, Del Re, Marzia, Antoniotti, Carlotta, Lonardi, Sara, Bergamo, Francesca, Loupakis, Fotios, Borelli, Beatrice, Marmorino, Federica, Citi, Valentina, Cortesi, Enrico, Moretto, Roberto, Ronzoni, Monica, Tomasello, Gianluca, Zaniboni, Alberto, Racca, Patrizia, Buonadonna, Angela, Allegrini, Giacomo, Ricci, Vincenzo, Di Donato, Samantha, Zagonel, Vittorina, Boni, Luca, Falcone, Alfredo, Danesi, Romano
Vydáno 2017Text -
13
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials Autor Fucà, Giovanni, Guarini, Vincenzo, Antoniotti, Carlotta, Morano, Federica, Moretto, Roberto, Corallo, Salvatore, Marmorino, Federica, Lonardi, Sara, Rimassa, Lorenza, Sartore-Bianchi, Andrea, Borelli, Beatrice, Tampellini, Marco, Bustreo, Sara, Claravezza, Matteo, Boccaccino, Alessandra, Murialdo, Roberto, Zaniboni, Alberto, Tomasello, Gianluca, Loupakis, Fotios, Adamo, Vincenzo, Tonini, Giuseppe, Cortesi, Enrico, de Braud, Filippo, Cremolini, Chiara, Pietrantonio, Filippo
Vydáno 2020Text -
14
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications Autor Moretto, Roberto, Elliott, Andrew, Zhang, Jian, Arai, Hiroyuki, Germani, Marco Maria, Conca, Veronica, Xiu, Joanne, Stafford, Phillip, Oberley, Matthew, Abraham, Jim, Spetzler, David, Rossini, Daniele, Antoniotti, Carlotta, Marshall, John, Shields, Anthony, Lopes, Gilberto, Lonardi, Sara, Pietrantonio, Filippo, Tomasello, Gianluca, Passardi, Alessandro, Tamburini, Emiliano, Santini, Daniele, Aprile, Giuseppe, Masi, Gianluca, Falcone, Alfredo, Lenz, Heinz-Josef, Korn, Michael, Cremolini, Chiara
Vydáno 2021Text -
15
TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-t... Autor Borelli, Beatrice, Moretto, Roberto, Lonardi, Sara, Bonetti, Andrea, Antoniotti, Carlotta, Pietrantonio, Filippo, Masi, Gianluca, Burgio, Valentina, Marmorino, Federica, Salvatore, Lisa, Rossini, Daniele, Zaniboni, Alberto, Zucchelli, Gemma, Martignetti, Angelo, Di Battista, Monica, Pella, Nicoletta, Passardi, Alessandro, Boccaccino, Alessandra, Leone, Francesco, Colombo, Camilla, Granetto, Cristina, Vannini, Francesca, Marsico, Valentina Angela, Martinelli, Erika, Antonuzzo, Lorenzo, Vitello, Stefano, Delliponti, Laura, Boni, Luca, Cremolini, Chiara, Falcone, Alfredo
Vydáno 2018Text